Cartesian Therapeutics, Inc. SEC filings RNAC
Cartesian Therapeutics, Inc. has 876 filings in SEC EDGAR's recent list, going back to Jan 5, 2009. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| S-8 | Employee stock plan registration | May 8, 2025 | — |
| POS AM | Filing | Jan 10, 2025 | — |
| POS AM | Filing | Jan 10, 2025 | — |
| 424B7 | Filing | Jan 8, 2025 | — |
| 424B7 | Filing | Jan 8, 2025 | — |
| 424B3 | Prospectus | Jan 8, 2025 | — |
| S-3 | Shelf registration | Dec 13, 2024 | — |
| S-3 | Shelf registration | Dec 13, 2024 | — |
| S-3 | Shelf registration | Dec 13, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 424B7 | Filing | Oct 1, 2024 | — |
| S-1/A | Amended registration statement | Sep 20, 2024 | — |
| S-1/A | Amended registration statement | Sep 9, 2024 | — |
| S-1 | Registration statement | Aug 2, 2024 | — |
| S-8 | Employee stock plan registration | Jan 12, 2024 | — |
| S-3/A | Filing | Dec 1, 2023 | — |
| S-3 | Shelf registration | Oct 25, 2023 | — |
| S-8 | Employee stock plan registration | Aug 17, 2023 | — |
| S-8 | Employee stock plan registration | May 5, 2022 | — |
| 424B5 | Prospectus supplement | Apr 7, 2022 | — |
| 424B5 | Prospectus supplement | Oct 25, 2021 | — |
| S-8 | Employee stock plan registration | May 13, 2021 | — |
| S-3 | Shelf registration | Aug 6, 2020 | — |
| S-8 | Employee stock plan registration | Jun 10, 2020 | — |
| S-3 | Shelf registration | Jan 29, 2020 | — |
| S-8 | Employee stock plan registration | Mar 25, 2019 | — |
| 424B5 | Prospectus supplement | Jan 24, 2019 | — |
| 424B5 | Prospectus supplement | Jan 22, 2019 | — |
| S-8 | Employee stock plan registration | Nov 8, 2018 | — |
| S-8 | Employee stock plan registration | Apr 3, 2018 | — |
| S-3 | Shelf registration | Aug 11, 2017 | — |
| S-3 | Shelf registration | Jul 13, 2017 | — |
| S-8 | Employee stock plan registration | Jun 24, 2016 | — |
| 424B4 | Prospectus | Jun 23, 2016 | — |
| S-1MEF | Filing | Jun 21, 2016 | — |
| FWP | Free writing prospectus | Jun 20, 2016 | — |
| S-1/A | Amended registration statement | Jun 20, 2016 | — |
| S-1/A | Amended registration statement | Jun 8, 2016 | — |
| S-1 | Registration statement | May 24, 2016 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Frederick, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1453687
- Former names
- SELECTA BIOSCIENCES INC (until Nov 13, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.